- Press Releases
- Media Kit
- Dr. Reddy's in News
- Statutory Communications
- Events
- Announcements
- Image Gallery
- Presentations & Webcasts
- Media Contacts
Deccan Chronicle - Business
22 February 2010
Father, scientist, pharma czar
Dr. Reddy’s Labs, the first private enterprise that took pharma MNCs head on, will shortly celebrate its silver jubilee, Dr. Anji Reddy and his son Satish Reddy talk exclusively to Deccan Chronicle about the remarkable journey of the largest Indian pharma firm.
Click Here for the Complete Story [PDF Format]
The Hindu - Business Line
19 February 2010
Reddy Formula:
25 years of robust, healthy way of doing business.
Click Here for the Complete Story [PDF Format]
Business World
August 31, 2009
Dr. Reddy's next Lab:
Dr. K Anji Reddy, Founder Chairman, intends to provide purified drinking water to villagers across India by 2020.
Click Here for the Complete Story [PDF Format]
India Today
August 24, 2009
Jobs over Degrees:
GV Prasad, Vice Chairman and CEO, talks about what it will take to transform the youth of India and create livelihood across the spectrum
Click Here for the Complete Story [PDF Format]
Business India
May 31, 2009
Innovating business models
Guest Column by: GV Prasad, Vice-Chairman & CEO Dr. Reddy’s
Serving non-traditional markets through innovation is success too.
Click Here for the Complete Story [PDF Format]
Financial Express
9th April, 2009
BEYOND THE BOARD
‘Entrepreneurship fuels innovation’
The first and the last word for the 41-year-old Satish Reddy is to provide affordable healthcare needs with personal commitments. Perhaps, this dictum helped the managing director and chief operating officer of NYSE-listed Dr Reddy’s Laboratories to be recognised as a Young Global Leader 2007 by the World Economic Forum.
Click Here for the Complete Story [HTML Format]
-
Financial Express
27th October, 2008
Sustainability is mandatory for business survival
Interview: GV Prasad, Vice-Chairman & CEO Dr. Reddy’s
Dr Reddy’s Laboratories is a leader in more ways than one. The company has a lesser-known distinction of being the first pharma company in India to publish a sustainability report. Last week the com-pany released its fifth annual report with the theme The Journey of Sustainability. GV Prasad, vice-chairman and chief executive officer, talks about the report and the company’s philosophy on sustainability in an email interview with the FE
Click Here for the complete Story[HTML Format]
The Economic Times
September 29, 2008
Helping hand of a medicine man
Just what constitutes the idea of a Corporate Citizen? Is it a company's CSR (corporate social responsibility) initiatives or does it entail an ethical way of doing business... And the honour went to Dr Reddy's Foundation (DRF), the CSR arm of Dr Reddy's Labs.
Click Here for the complete Story[HTML Format]
Business Week
March 17, 2008
Dr. Reddy's Mode of Discovery
The Indian drugmaker's CEO explains the company's move from generic offerings, and its intent on securing a spot among the world's top 25 pharma companies.
Click Here for the complete Story[HTML Format]
Bio Spectrum
March, 2008
Top 20 Life Sciences Institutes of India
Being the most cost effective and compliant contract manufacturing hub (for pharmaceuticals) in Asia, Indian CMO's are now becoming more innovative, diversified and are adopting state-of-the-art process technology and international standards to stay competitive.
Click Here for the complete Story[PDF Format]
Business Today
March, 2008
Meet Anji Reddy, The Philanthropist
The Chairman of Dr. Reddy's Labs is morphing into one of India's most committed givers. Dr. Reddy's eponymous founder in now attacking social problems.
Click Here for the complete Story[PDF Format]
-
Bio Spectrum
March, 2008
Dr. Reddy's aims to be a Biosimilar leader
DHyderabad-based, Dr. Reddy's Laboratories, the $1.2 billion Indian Pharma major, and one of the world's leading generics players, is making determined efforts to increase its portfolio of biosimilar products and become a global leader in the next decade in this space. A spacial report from the company's Hyderabad campus.
Click Here for the complete Story[PDF Format]
Outlook - Profit
March, 2008
There are plenty of opportunities in emerging markets
Dr. Reddy's Laboratories' COO and MD Satish Reddy lays out his plans to take one of India's biggest pharmaceutical companies to the next level of growth.
Click Here for the complete Story[PDF Format]
Global Logistics & Supply Chain Strategies
February, 2008
TGeneric Drug Manufacturer's Supply Chain Ills
Triple-digit growth rates, regulatory issues and the highly competitive nature of the generic drug market posed complexity issues for this India-based pharmaceutical company. UPS Supply Chain Solutions helped Dr. Reddy's sort it all out.
Click Here for the complete Story[PDF Format]
-
Business Today
January 27, 2008
Trials by Fire
Pharma entrepreneurs like Ajay Piramal and Anji Reddy are betting on drug discovery to double the industry's value to $129 billion by 2015.
Click Here for the complete Story[PDF Format]
Money Today
December 27, 2007
From Babu to Corporate Honcho
Career as Asset - Case Studies of successful career switches Prabir Jha's career focus did not waver nor did his professional plans go awry after quitting his cushy government job.
Click Here for the complete Story[PDF Format]
-
Business India
December 16, 2007
Betting on biotech
Dr. Reddy's is concentrating now on biotechnology-based products and going for acquisitions to provide a base for launching them
Click Here for the complete Story[PDF Format]
Ethical Corporation
October 2007
Targeting the poor sweetens the profits pill
Indian pharma multinational Dr Reddy’s chief executive G V Prasad says that patient needs and shareholder value go hand-in-hand.
Click Here for the complete Story[PDF Format]
PharmaTech.com
September 2, 2007
Leading the Pack - Lessons learned from the Top
Life isn't so relaxing at the top. Ranking first among Indian pharmaceutical companies, Dr. Reddy's Laboratories (Hyderabad) is in itself a model that a lot of companies in the Indian industry have either drawn inspiration from or at best imitated.
Click Here for the complete Story[HTML Format]
-
Business Today
November 18, 2007
The Best Companies to work for in India
A BT-Mercer-TNS survey of India's best employers
Click Here for the complete Story[PDF Format]
Los Angeles Times
June 9, 2007
Similarities in consumer bases help make the region a natural market.
Meet Anji Reddy, The Philanthropist
Ask for directions to Dr. Reddy's Laboratories Ltd. in this industrial city in central Mexico and locals will give you a curious look.Many are unfamiliar with the drug maker, one of India's largest pharmaceutical companies, which purchased a production facility here in late 2005 for about $59 million.
It may be the first time they've heard of an Indian company doing business in Mexico, but it won't be the last.
Click Here for the complete Story[HTML Format]
Rediff News
June 12, 2007
Dr Reddy's: From Rs 25 lakh to Rs 5,800 crore
The Patents Act signalled the arrival of good times for the pharmaceutical companies. Soon after the Act was announced, hundreds of companies started reverse engineering of western pharmaceutical products. There was a virtual explosion in the pharma space, with entrepreneurs making most of this opportunity.
Click Here for the complete Story[PDF Format]
Outlook - Business
May 5, 2007
Globe, A Place For You and Me
Building global firms may not always be a stuff of fairy tales. Stick to a few basic principles, most often, you're there. Dr. Reddy's has a story for corporations looking for an international footprint.
GV Prasad Vice Chairman &CEO, Dr. Reddy's Laboratories
Click Here for the complete Story[PDF Format]
Newsweek International
March 2007
Foe Turned Friend
Indian generic-drug makers once bedeviled Big Pharma; now they may be its best hope for success.
Click Here for the complete Story[HTML Format]
Modern Pharmaceuticals
February - March 2007
Leaders Speak Dr. K. Anji Reddy.
"Building a global generic business and increasing geographical expansion are key priorities for us"
Click Here for the complete Story[PDF Format]
Bloomberg Markets
January 2007
Dr. Reddy's Pfizer Fixation
Special feature on Dr. Reddy's Labs
India's maker of generic Prozac and Cipro, stung by flops and failed patent challenges, is staking its future on its founder's quest to create a homegrown blockbuster drug.
Click Here for the complete Story[PDF Format]
-
Outlook - Business
December 5, 2006
Carry on, Dr Reddy
Special feature on Dr. Reddy's Labs
The good times have started to roll for the pharma major, thanks to some big generic orders, acquisitions and research breakthroughs, but sustainability is what counts.
Click Here for the complete Story[PDF Format]
INDIA TODAY
December, 2006
"First Person" with Dr.K.Anji Reddy, Chairman"
Click Here for the complete Story[PDF Format]
-
Business World
November 20, 2006
"First Person" with Dr.K.Anji Reddy, Chairman
Indian companies and boutique western firms are forming research alliances that could challenge Big Pharma.
Click Here for the complete Story[PDF Format]
-
Business World
November 13, 2006
Dr. Reddy's on a high.
Click Here for the complete Story[PDF Format]
-
Business Today
November 5, 2006
The Best Companies to work for in India
A BT-Mercer-TNS survey of India's best employers
The good times have started to roll for the pharma major, thanks to some big generic orders, acquisitions and research breakthroughs, but sustainability is what counts.
Click Here for the complete Story[PDF Format]
THE WEEK
September 24, 2006
Most awaited Drugs
Indian companies get ready to serve better and cheaper medicines for asthma to cardiocare and cancer.
Click Here for the complete Story[PDF Format]
FOCUS Reports
July, 2006
Exclusive Interviews - Dr.K.Anji Reddy, Chairman
March, 2006
Exclusive Interviews - Mr.G.V.Prasad, CEO &Vice-Chairman
Click Here for the complete Story[PDF Format]
Express Pharma
16 - 30 June, 2006
Winners Chronicle
Pharma Excellence Awards 2006
Click Here for the complete Story[PDF Format]
-
Businessworld
June 19, 2006
"The Race to create India's first new drug" - Dr. Reddy's diabetes drug is entering the final phase of clinical trials. Three other Indian companies have molecules in advanced phases of testing. They aim to hit the market as early as 2009.
Click Here for the complete Story[PDF Format]
-
Business Today
May 21, 2006
" Back In The Reckoning" - Some smart derisking strategies, a pick up in international markets and better prospects in the US have boosted Dr Reddy’s earning and stock, making it the hot pharma stock that it once was.
Click Here for the complete Story[PDF Format]
-
Businessworld
May 15, 2006
"The $50 – billion Opportunity" -Ranbaxy and Dr. Reddy’s may have found the formula for cracking the US generics market.
Click Here for the complete Story[PDF Format]
-
Businessworld
May 01, 2006
"This combination fits perfectly" - EUROPE has emerged as a lucrative hunting ground for Indian pharmaceutical companies. Last month, Dr. Reddy’s acquired betapharm, Germany’s third-largest generics company.
Click Here for the complete Story[PDF Format]
Scrip Magazine
April, 2006
"Great minds think alike" - Observers will note clear parellels between Malvinder Singh and Satish Reddy's young business lives - both US-educated, the men have quickly risen to the top of two Indian pharma giants.
Click Here for the complete Story[PDF Format]
-
India Today
April 03, 2006
"Prescription for Success" - With the Rs 2,500 crore takeover of a top German pharma firm, Dr Reddy’s Laboratories not only ensures a strategic global presence, but also enters the top-three league on home ground.
Click Here for the complete Story[PDF Format]
-
Businessworld
April 03, 2006
"Compound Cure" - The world's first polypill, a multiple product pill for heart ailments, has been developed by Dr.Reddy's.
Click Here for the complete Story[PDF Format]
-
Businessworld
March 20, 2006
"Europe Ahoy!" - Dr. Reddy’s Laboratories acquires betapharm, Germany’s fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company.
Click Here for the complete Story[PDF Format]
International Herald Tribune
February 16, 2006
"Dr. Reddy's is expanding into Europe" - The Indian drug maker Dr. Reddy's Laboratories said Thursday that it would buy Betapharm Arzneimittel for E480 million to expand in Germany, Europe's biggest pharmaceutical market.
Click Here for the complete Story[HTML Format]
Management Scope
February, 2006
"Family companies form the back bone of the Indian economy." - This is true for the pharma industry too. At medicine maker Dr. Reddy's - the father, son and son-in-law sit at the governing board table. Their most formidable challenge being Alliances with Western companies. (article in Dutch)
Click Here for the complete Story[PDF Format]
BusinessWeek.com
February 08, 2006
"Generics Make a Name for Themselves" - In an otherwise lackluster pharma market, stocks like Dr. Reddy's Labs are surging. With a slather of patents set to expire, their prospects look good.
Click Here for the complete Story[HTML Format]
Chemical & Engineering News
January 30, 2006
"Dr.Reddy's gambit" - Frequent drug industry nemesis seeks to boost its custom manufacturing business.
Click Here for the complete Story[PDF Format]
Business Today
December 04, 2005
The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, strong product pipelines and a tight control on costs, the future is definitely not break.
December 04, 2005
The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, strong product pipelines and a tight control on costs, the future is definitely not break.
BusinessWeek.com
November 30, 2005
The Other Disease Plaguing Asia - Avian flu may get the headlines, but the health risks from diabetes are more severe. Help may come from India's and China's pharmas
November 30, 2005
The Other Disease Plaguing Asia - Avian flu may get the headlines, but the health risks from diabetes are more severe. Help may come from India's and China's pharmas
Business Today
October 23, 2005
Drugs that talk - Dr. Reddy's Labs signs another innovative deal, this time for discovery and development
October 23, 2005
Drugs that talk - Dr. Reddy's Labs signs another innovative deal, this time for discovery and development
Business India
October 10 - 23, 2005
Pillar to success - This year Dr Reddy's Laboratories completes five years of its Chinese Joint venture operations, Kunsham Rotam Reddy Pharmaceutical Co Limited (KRRP).
October 10 - 23, 2005
Pillar to success - This year Dr Reddy's Laboratories completes five years of its Chinese Joint venture operations, Kunsham Rotam Reddy Pharmaceutical Co Limited (KRRP).
CNN.com
September 07, 2005
Imitate gives way to "innovate" - India's pharmaceutical industry increasingly turning to research - A CNN Report
September 07, 2005
Imitate gives way to "innovate" - India's pharmaceutical industry increasingly turning to research - A CNN Report
Business Today
August 28, 2005
Riding Out Of: Things are looking up at Dr Reddy's Labs. First quarter profits are up and the stock has gained some of the lost ground . Finally, the worst may be behind the pharma major.
August 28, 2005
Riding Out Of: Things are looking up at Dr Reddy's Labs. First quarter profits are up and the stock has gained some of the lost ground . Finally, the worst may be behind the pharma major.
India Today
August 22, 2005
Search Engines: "India has an opportunity in R&D if we think out of the box. In each problem, there is an opportunity."
Kallam Anji Reddy, Chairman, DRL
August 22, 2005
Search Engines: "India has an opportunity in R&D if we think out of the box. In each problem, there is an opportunity."
Kallam Anji Reddy, Chairman, DRL
Business Today
July 31, 2005
Portal of Hope: In the six years since it was set up, Dr. Reddy's Foundations' Livelihood Advancement Business School has helped prepare some 35,000 underpriviledged youngsters for entry-level jobs.
July 31, 2005
Portal of Hope: In the six years since it was set up, Dr. Reddy's Foundations' Livelihood Advancement Business School has helped prepare some 35,000 underpriviledged youngsters for entry-level jobs.
Business Today
India Inc: Going Global
Collector's Edition Volume II
March , 2005
India Inc: Going Global - CEOs from leading Indian companies shares their views.
GV Prasad, Executive Vice Chairman and CEO, Dr. Reddy’s Laboratories, shares his thoughts on the company's 'Globalisation Journey'.
India Inc: Going Global
Collector's Edition Volume II
March , 2005
India Inc: Going Global - CEOs from leading Indian companies shares their views.
GV Prasad, Executive Vice Chairman and CEO, Dr. Reddy’s Laboratories, shares his thoughts on the company's 'Globalisation Journey'.
Business Today
December 04, 2005
The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, strong product pipelines and a tight control on costs, the future is definitely not break.
December 04, 2005
The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, strong product pipelines and a tight control on costs, the future is definitely not break.
Business Today
November 21, 2004
The best companies to work for in India
Dr. Reddy's is rated number seven across all sectors and the only pharmaceutical company to make the grade …
November 21, 2004
The best companies to work for in India
Dr. Reddy's is rated number seven across all sectors and the only pharmaceutical company to make the grade …
Business World
November 8, 2004
India's most respected companies
Dr. Reddy's is rated number six across all sectors and number one in the pharmaceutical sector …
November 8, 2004
India's most respected companies
Dr. Reddy's is rated number six across all sectors and number one in the pharmaceutical sector …
www.businessworldindia.com
November 8, 2004
An interview with Dr. Uday Saxena, chief scientific officer, Dr. Reddy’s.
November 8, 2004
An interview with Dr. Uday Saxena, chief scientific officer, Dr. Reddy’s.
CFO Asia
India's generic-drug companies make an audacious bid for global recognition.
India's generic-drug companies make an audacious bid for global recognition.
Business World
August 16, 2004
A Point to Prove
Dr. Reddy's is sticking to its innovation-led strategy …
August 16, 2004
A Point to Prove
Dr. Reddy's is sticking to its innovation-led strategy …
Business Today
India Inc : Going Global, Collector's Edition Volume I
May, 2004
The Indian MNCs
While Dr. Reddy's wants to boost its generics and bulk drugs business, its long-term focus is on developing new drugs of its own.
India Inc : Going Global, Collector's Edition Volume I
May, 2004
The Indian MNCs
While Dr. Reddy's wants to boost its generics and bulk drugs business, its long-term focus is on developing new drugs of its own.
Business Today
February 15, 2004
India’s Journey to Becoming A Developed Nation Dr. Anji Reddy's recipe to make India a developed economy.
February 15, 2004
India’s Journey to Becoming A Developed Nation Dr. Anji Reddy's recipe to make India a developed economy.
Business World
August 27, 2003
Free to Experiment
Its all about giving every employee the space to do his own thing.
August 27, 2003
Free to Experiment
Its all about giving every employee the space to do his own thing.
Industry2
August, 2003.
A well-researched approached
It was only a year ago that Dr. Reddy's (DRL) was selected by Forbes Global in its "Best under a Billion, Forbes Global Best Small companies for 2002". It was the second consecutive year for the company....
August, 2003.
A well-researched approached
It was only a year ago that Dr. Reddy's (DRL) was selected by Forbes Global in its "Best under a Billion, Forbes Global Best Small companies for 2002". It was the second consecutive year for the company....
Business Today
Collector's Edition Volume IV, 2003.
The New Paradigm Shift
Innovation & Globalisation
Mr GV Prasad, CEO, Dr. Reddy's elaborates on how innovation & entrepreneurship have driven the globalisation efforts of the company.
Collector's Edition Volume IV, 2003.
The New Paradigm Shift
Innovation & Globalisation
Mr GV Prasad, CEO, Dr. Reddy's elaborates on how innovation & entrepreneurship have driven the globalisation efforts of the company.
Indian Management
July, 2003.
Bringing Innovation to Social Goals
The Dr. Reddy's Foundation for Human and Social Development brings innovation and entrepreneurship to the business of focussing on children and youth at risk among the urban poor.
July, 2003.
Bringing Innovation to Social Goals
The Dr. Reddy's Foundation for Human and Social Development brings innovation and entrepreneurship to the business of focussing on children and youth at risk among the urban poor.
Business Today
June 22, 2003
India's Best Managed Companies
Timely manoeuvres have made it the most innovative company in the industry. And its bid to be a billion-dollar pharma major in another five years depends on that streak of good management continuing.
June 22, 2003
India's Best Managed Companies
Timely manoeuvres have made it the most innovative company in the industry. And its bid to be a billion-dollar pharma major in another five years depends on that streak of good management continuing.
Far Eastern EconomicReview
Apr 24, 2003.
INNOVATION: Indian Drug Companies Crack The U.S. Market
India's patent-busting drug firms are grabbing a piece of the lucrative U.S. medicine market with their affordable copies of costly drugs. How? By waging court battles with pharmaceutical giants.
Apr 24, 2003.
INNOVATION: Indian Drug Companies Crack The U.S. Market
India's patent-busting drug firms are grabbing a piece of the lucrative U.S. medicine market with their affordable copies of costly drugs. How? By waging court battles with pharmaceutical giants.
Businessworld
Mar 17, 2003.
Origin Of A Species
Aurigene is one of its kind. It shows how to get global talent to work in India.
Mar 17, 2003.
Origin Of A Species
Aurigene is one of its kind. It shows how to get global talent to work in India.
International Herald Tribune
Feb11, 2003.
Dr. Reddy looks to next level
Not content to copy others, firm seeks to develop its own drugs.
Feb11, 2003.
Dr. Reddy looks to next level
Not content to copy others, firm seeks to develop its own drugs.
Business World
January , 2003
Dr. Reddy's features as the 7th most respected company.
January , 2003
Dr. Reddy's features as the 7th most respected company.
Outlook Money
October , 2002
The Value Creator Award for consistently growing shareholder value.
October , 2002
The Value Creator Award for consistently growing shareholder value.
Business World
October , 2002
India's pharma leaders discuss how we can be in the global big league.
October , 2002
India's pharma leaders discuss how we can be in the global big league.
Far Eastern Economic Review
September 2002
Far Eastern Economic Review, a leading business magazine in Asia and part of the Dow Jones Group, in conversation with Mr GV Prasad, CEO, Dr. Reddy's on the challenges facing the Company as it continues on its path to globalization.
September 2002
Far Eastern Economic Review, a leading business magazine in Asia and part of the Dow Jones Group, in conversation with Mr GV Prasad, CEO, Dr. Reddy's on the challenges facing the Company as it continues on its path to globalization.
Business Today
September , 2002
For long entrepreneur-driven, Dr. Reddy's lab is now focussing on building an organisation with leaders at every level. The idea: become a marketing and research powerhouse.
September , 2002
For long entrepreneur-driven, Dr. Reddy's lab is now focussing on building an organisation with leaders at every level. The idea: become a marketing and research powerhouse.
Financial Times
June 6, 2002
Drugs innovation is just what the Doctor ordered
"Innovation is where long-term value lies." says Mr. Prasad.
June 6, 2002
Drugs innovation is just what the Doctor ordered
"Innovation is where long-term value lies." says Mr. Prasad.
Scrip Magazine
May, 2002
Dr Anji Reddy put the Indian Pharma not just on the map but onto the New York Stock Exchange.
May, 2002
Dr Anji Reddy put the Indian Pharma not just on the map but onto the New York Stock Exchange.
Business India
December, 2001
Dr. Anji Reddy has demonstrated that a highly focussed small pharma company can also play in the big league of drug discoverers.
December, 2001
Dr. Anji Reddy has demonstrated that a highly focussed small pharma company can also play in the big league of drug discoverers.
Forbes Global
December 2001
Pill factory to the world:
India's drug industry is growing beyond cheap knockoffs of Western innovation.
December 2001
Pill factory to the world:
India's drug industry is growing beyond cheap knockoffs of Western innovation.
Business Today
July, 2001
The Molecule Millionaires - By focussing on drug research, a clutch of avant-garde drug companies is trying to create a new global niche for itself.
July, 2001
The Molecule Millionaires - By focussing on drug research, a clutch of avant-garde drug companies is trying to create a new global niche for itself.
Designed by